Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.

Cancer discovery - 1 Feb 2014

Kerns Sarah L, Ostrer Harry, Rosenstein Barry S

Abstract excerpt

UNLABELLED: Normal-tissue adverse effects following radiotherapy are common and significantly affect quality of life. These effects cannot be accounted for by dosimetric, treatment, or demographic factors alone, and evidence suggests that common genetic variants are associated with radiotherapy adverse effects. The field of radiogenomics has evolved to identify such genetic risk factors. Radiogenomics has two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genome-Wide Association Study
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Prognosis

Share to Radiation Injuries

Share to Radiation Tolerance

Share to Radiotherapy

Source

Open in PubMed Open full text

Identifiers

PMID: 24441285
DOI: 10.1158/2159-8290.CD-13-0197
PMCID: PMC3946319

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.PMID 24441285Read ↗

The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.Semantic proximity Read ↗

Radiogenomics: the search for genetic predictors of radiotherapy response.Semantic proximity Read ↗

Genetics and genomics of radiotherapy toxicity: towards predictionSemantic proximity Read ↗

Radiogenomics - current status, challenges and future directions.Semantic proximity Read ↗

Radiogenomics: the promise of personalized treatment in radiation oncology?Semantic proximity Read ↗

Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Semantic proximity Read ↗

Radiogenomics: towards a personalized radiation oncology.Semantic proximity Read ↗

Finding the genetic determinants of adverse reactions to radiotherapy.Semantic proximity Read ↗

Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapy.Semantic proximity Read ↗

Radiation biology and oncology in the genomic eraSemantic proximity Read ↗

Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review.Semantic proximity Read ↗

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.